[Action of aluminum bis-parachlorophenoxyisobutyrate (2CPIBA) on various hyperlipoproteinemias: initial results].
D000328:Adult; D000368:Aged; D000535:Aluminum / Q000627:therapeutic use*; D002087:Butyrates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged
D002087:Butyrates; D008074:Lipoproteins; D000535:Aluminum
L'action du bisparachlorophénoxyisobutyrate d'aluminium (2 CPIBA) sur diverses hyperlipoprotéinémies: premiers résultats.